Study ID: ACR16 C008
Study Title
- A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
Teva Identifier
- ACR16 C008
ClinicalTrials.gov Identifier
- NCT00665223
Study Status
- Completed
Trial Condition(s)
- Huntington's Disease
Interventions
- Drug: ACR16 | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 30 Years and older
Trial Duration
- 04/01/2008 - 06/01/2011
Phase
- Phase 3
Study Type
Interventional
